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Objective: Repairing articular cartilage is clinically challenging. We investigated a simple, effective and
clinically feasible cell-based therapeutic approach using a poly(lactide-co-glycolide) (PLGA) scaffold
seeded with autologous endothelial progenitor cells (EPC) to repair a full-thickness osteochondral defect
in rabbits using a one-step surgery.
Methods: EPC obtained by purifying a small amount of peripheral blood from rabbits were seeded into a
highly porous, biocompatible PLGA scaffold, namely, EPC-PLGA, and implanted into the osteochondral
defect in the medial femoral condyle. Twenty two rabbits were randomized into one of three groups: the
empty defect group (ED), the PLGA-only group or the EPC-PLGA group. The defect sites were evaluated 4
and 12 weeks after implantation.
Results: At the end of testing, only the EPC-PLGA group showed the development of new cartilage tissue
with a smooth, transparent and integrated articular surface. Moreover, histological analysis showed
obvious differences in cartilage regeneration. At week 4, the EPC-PLGA group showed considerably
higher TGF-b2 and TGF-b3 expression, a greater amount of synthesized glycosaminoglycan (GAG) con-
tent, and a higher degree of osteochondral angiogenesis in repaired tissues. At week 12, the EPC-PLGA
group showed enhanced hyaline cartilage regeneration with a normal columnar chondrocyte arrange-
ment, higher SOX9 expression, and greater GAG and collagen type II (COLII) content. Moreover, the EPC-
PLGA group showed organized osteochondral integration, the formation of vessel-rich tubercular bone
and signiﬁcantly higher bone volume per tissue volume and trabecular thickness (Tb.Th).
Conclusion: The present EPC-PLGA cell delivery system generates a suitable in situ microenvironment for
osteochondral regeneration without the supplement of exogenous growth factors.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Damaged articular cartilage has poor self-repairing capabilities
using regenerating hyaline cartilage. Chondrocytes, the cells
responsible for hyaline cartilage regeneration, are conﬁned to the
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s Research Society International. Pgrowth factors to and from the cartilage is primarily through the
synovial ﬂuid; also, nutritional supply may be through the sub-
chondral bone as a second way1,2. Among the cartilage lesions,
osteochondritis dissecans (OCD) occur most frequently in the knee
due to a full-thickness defect in the hyaline cartilage and under-
lying bone tissue3. The current therapeutic options for an osteo-
chondral defect include microfracture surgery, autologous
chondrocyte implantation (ACI) and osteochondral transplantation
(OCT)4e6. Microfracture surgery is usually used for small focal
cartilage defects (<2 cm2) by stimulating the surrounding bone
marrow-derived mesenchymal stem cells (BMSC) to generate new
cartilage tissue7. However, this newly formed cartilage is mostly
ﬁbrocartilage. ACI or OCT derived from self-donor is another further
choice for osteochondral lesions8. ACI is limited by high costs andublished by Elsevier Ltd. All rights reserved.
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of cells (up to 3e4 weeks). ACI also carries a higher risk of
contamination and severe postoperative pain caused by the two-
step surgery. Moreover, it also often results in ﬁbrocartilage
growth9. Disadvantages of OCT include the limited morbidity of the
injured site, a shortage of donors, and the poor integration of the
host’s tissue in the patient10. Taken together, there is still a lack of a
standard treatment protocol for cartilage injuries.
Recently, the application of therapeutic cell engineering with
scaffolding substitutes has become a promising treatment strategy
for osteochondral repair. We have previously demonstrated that a
degradable porous poly(lactide-co-glycolide) (PLGA) scaffold
created a temporary space for neo-tissue development and facili-
tated the regeneration process of cartilage defects11e13. PLGA has
been used as a biomaterial in FDA-approved medical devices, in
orthopedic applications and extensively in pre-clinical trials14e16.
Clinically, autologous cells, such as BMSC, are commonly used in
cell-based therapies with a minimal immune response. BMSC have
been used in some in vivo studies17,18 and in clinical trials of
osteochondral repair19,20. However, BMSC commonly require a
prolonged period in speciﬁc culture conditions (i.e., supplemental
growth factors) before they can differentiate into chondrocytes,
which are essential for the formation of hyaline cartilage.
Since endothelial progenitor cells (EPC) were ﬁrst discovered in
1997, evidence has continued to accumulate that EPC provide a high
capacity for regeneration and vasculogenesis in different tissues via
direct cell fusion and indirect paracrine mechanisms. Circulating
EPC are often adopted and cultured inmedium favoring endothelial
differentiation, inwhich isolation could dispel donor site morbidity
risks and hence provide an ideal autologous cell source for further
therapies. Therapeutic applications for EPC have been reported for
cardiovascular diseases21,22 and bone regeneration23e25. However,
no previous studies have evaluated the effect of EPC in cartilage
repair.
Accordingly, we hypothesized that a porous PLGA scaffold can
provide a degradable structure and a topographical cue to promote
cell migration, attachment, proliferation, and tissue regeneration.
Meanwhile, EPC will offer a biological cue and change in situ the
microenvironment or niche, which will trigger the surrounding
therapeutic stem cells to commence self-renewal, proliferation,
differentiation, and mobilization, and aid chondrogenesis, osteo-
genesis25,26 and angiogenesis27,28, thereby remedying osteochon-
dral defects. The combined effects could help achieve osteochondral
repair without the supplement of exogenous growth factors.
Methods
Isolation of EPC
Peripheral blood was obtained from New ZealandWhite rabbits
via the peripheral ear artery (10 ml/kg). Peripheral blood mono-
nuclear cells were isolated by density gradient centrifugation with
Ficoll-Plaque Plus (Amersham Biosciences). Subsequently, mono-
nuclear cells were washed and then incubated on culture dishes
that were coated with ﬁbronectin and supplied with endothelial
growth medium (EGM)-2 (Cambrex Corp). After 7 days of incuba-
tion, the adherent cells (early EPC) were harvested by trypsiniza-
tion for analysis or transplantation. The EPC isolated from rabbits
were also characterized and conﬁrmed as previously described22.
Brieﬂy, cells were incubated with acetyl-LDL (10 mg/ml; Molecular
Probes, Carlsbad, CA) and isolectin (5 mg/ml; Molecular Probes). The
staining of acetyl-LDL and isolectin in cultured EPC was detected
under ﬂuorescence confocal microscopy at absorptionwavelengths
of 555 and 495 nm, respectively. In addition, the expression of Flk-1
(a speciﬁc endothelial cell marker; Santa Cruz Biotechnology, SantaCruz, CA) after processing indirect immunoﬂuorescence (IF) stain-
ing was analyzed by confocal microscopy.
Preparation of porous PLGA and EPC-PLGA scaffolds
A porous PLGA (lactide/glycolide ratio of 85/15, molecular
weight 50e75 kDa) scaffold with a compressive modulus of
0.65  0.11 MPa, pore size of 395.27  11.65 mm, and porosity over
90% was fabricated via the salt-leaching technique, as described in
our prior work12. In brief, 4 ml of 20%w/v PLGA chloroform solution
was ﬁrst mixed with 7.2 g of sodium chloride. This mixture was
poured into cylindrical molds and lyophilized for 1 day to form the
PLGA sponges. The cylindrical sponges were then immersed in
deionized water to dissolve the porogen. The sponges were cut into
cylinders of 3 mm in height and 3 mm in diameter. After 7 days of
incubation, adherent autologous EPCwere trypsinized, centrifuged,
resuspended in medium at a concentration of approximately
5.0 105 cells/mL, and seeded into PLGA scaffolds using a 0.43-mm
syringe for 3-D cultures. The cultures were maintained in 24-well
culture plates for 4 h, and fresh medium was supplied before in-
cubation for 1 day at 37C in a 5% CO2 environment. Before the
delivery of the autologous cell-seeded scaffolds to animals, the
attachment of EPC onto the PLGA (EPC-PLGA) scaffolds was
conﬁrmed using a scanning electron microscope, and the attach-
ment ratiowas calculated. The harvested EPCwere labeledwith cell
tracker (CM-DiI, Molecular Probes)29 immediately before trans-
plantation to trace the fate of these cells.
Assessment of EPC attachment and viability in vitro
EPC were stained by trypan blue, and an automated cell counter
(Countess, Invitrogen) was used to determine the differences be-
tween the numbers of seeded and ﬂoating cells after 1 day. The
bottoms of the 24-well culture plates were initially covered with
PVC to prevent cell attachment and offset of the errors. Cell viability
was assessed using a standard MTS-based assay (Promega)11 to
evaluate the number of viable adherent cells on scaffolds by
mitochondrial succinate dehydrogenase activity. Quantitative data
for the absorbance values were obtained at awavelength of 490 nm
via an ELISA reader (Sunrise, Tecan). The scanning electron micro-
scope (LV-SEM, JSM-6390LM) image shows cells attached
morphologically onto the PLGA scaffolds. The dehydrated samples
were sputter coated with a thin layer of gold and imaged by SEM at
an acceleration voltage of 20 keV.
Transplantation of EPC-seeded PLGA scaffolds in rabbits
All experimental animal procedures were approved by the An-
imal Care and Use Committee of National Cheng Kung University
and performed in accordance with strictly aseptic techniques. An
osteochondral defect model was established, as described in our
previous study12. Brieﬂy, 22 4- to 5-month-old New Zealand White
male rabbits (Livestock Research Institute, Taiwan), weighing 2e
3 kg, were used in the study, providing 44 knees. Anesthesia was
induced by a subcutaneous injection of Zoletil 50 (25 mg/kg) and
maintained with a volatile halation of isoﬂurane (2% v/v in oxygen).
Following anesthesia, both legs were shaved, brushed, disinfected
with ethanol-iodine, and covered with an aseptic drape. The knee
was exposed by an anteromedial parapatellar longitudinal incision
and a capsular incision. To limit the amount of spontaneous heal-
ing, full-thickness cartilage defects (3 mm in diameter and 3 mm in
depth) were created on the weight-bearing zone of the medial
femoral condyle30. The full-thickness defect was created using an
electric drill, and the joint was irrigated immediately with sterile
isotonic saline. After removing the debris from the defect, the
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groups: the empty defect (ED) group, the PLGA group or the EPC-
PLGA group. In the EPC-PLGA and PLGA-only groups, PLGA scaf-
folds were gently inserted and press ﬁt into the defect hole and
then ﬂushed with normal saline. The patella was repositioned, and
the wound was closed in layers. After the surgical procedure, the
rabbits were housed singly and allowed free cage activity with
unrestricted weight-bearing activity. Enroﬂoxacin (25 mg/kg) and
an analgesic (Ketoprofene) were administered subcutaneously for 3
days. A neck collar was applied to prevent the animals from biting
the wound. The rabbits were euthanized 4 or 12 weeks after the
operation with an intravenous injection of 120 mg/kg pentobar-
bital. Overall, there were eight knees in the EPC-PLGA group, and
six knees in each of the ED and PLGA-only groups at each experi-
mented time point (Supplementary Data S1). Each distal femur was
harvested for further examinations.
Macroscopic evaluations
After postoperative euthanasia at 4 weeks (ED and PLGA groups:
six knees each; EPC-PLGA group: eight knees; Sham: four knees)
and 12 weeks (ED and PLGA groups: six knees for each; EPC-PLGA
group: eight knees), the macroscopic scores of the reparative tissue
were blindly assessed by two researchers based on our previous
scoring system12, which assesses coverage, tissue color, and surface
condition. The maximum total score is 12 points (Supplementary
Data S2).
Micro-CT evaluations
To individually evaluate qualitative and quantitative measure-
ments of the bone regeneration level within the defects, medial
femoral condyles in the ED and PLGA groups were scanned using a
microtomograph 1076 scanner (Skyscan). The ED (six knees), PLGA
(six knees), EPC-PLGA (eight knees) groups were analyzed at each
time point in comparison with the sham group (four knees). The
formalin-ﬁxed rabbit femur ends were loaded on a sample holder
with the femur axis perpendicular to the scanning plane. Regarding
the parameters of the X-ray source presenting mineralized tissue,
the voltage was set to 50 kV, and the current was set to 160 mA12.
The samples were scanned through a 360 rotation angle with a
rotation interval of 1 and a pixel size with 18-mm resolution. The
Skyscan software package was used to analyze the image data and
visualize the new bony matrix. From the CT data set, a cylindrical
region of interest (ROI) 3 mm in diameter within the repaired site,
which corresponds to the original defect region, was selected for
analysis. The volume and diameter of the bone growth were
measured as bone volume per tissue volume (BV/TV) and trabec-
ular thickness (Tb.Th), respectively.
Staining, histology, scores, and immunostaining
For histological sections, all samples were prepared by the Chi-
Mei Medical Center Department of Pathology. The samples were
treated in accordance with standard processing, which in-
corporates 10% formalin ﬁxation, gradient dehydration in ethanol
dilutions, decalciﬁcation, inﬁltration and parafﬁn embedding. The
samples were cut into four-micron-thick sections and stained with
hematoxylin and eosin (H&E) to assess the cell morphology and
inﬂammatory responses, Masson’s trichrome to assess the overall
collagen syntheses and alignment, and Alcain blue to assess the
glycosaminoglycan (GAG) content. The samples were observed
using a microscope (Olympus BX51). The images of the sections
were recorded using a digital CCD (Olympus DP70). Moreover, to
determine the content of collagen type I (COLI) (ﬁbrocartilage) & II(hyaline cartilage), SOX9 (chondrocyte), CD31 and the Von Wille-
brand factor (vWF, an endothelial marker) in the regenerated tis-
sues, the sections were evaluated by either immunohistochemistry
(IHC) or IF analysis. All primary antibodies were 1:100 dilutions. All
staining protocols followed the manufacturers’ recommended
guidelines. For IHC analysis, we used the rabbit/mouse HRP/DAB
polymer detection (BioSB) kit. For IF analysis, we used the FITC- and
Rhodamine Red-conjugated goat antiemouse IgG antibody kit
(Jackson ImmunoResearch Laboratory). The histological scores of
the regenerated tissue were assessed blindly by two investigators
according to our previous study12. The main categories of the his-
tological scores include the overall ﬁlling assessment, bone ﬁlling,
subchondral morphology, bonding to bone surface morphology,
cartilage thickness, surface regularity, chondrocyte clustering, neo-
surface GAG&Cell content, and adjacent surface GAG&Cell content.
Furthermore, we evaluated PLGA degradation after implantation
(Supplementary Data S3). Moreover, vascular density was deter-
mined by the number of vessels per area of each histology image
under 200 magniﬁcation.
Statistical analysis
All of the data are shown as the mean  95% conﬁdence in-
tervals (CI). Statistical analyses were performed using the SPSS
v17.0 software package. Due to the concern of outcome dependence
by using bilateral knees of animal in individual group31, gross
appearance scores, histology scores, and quantitative micro-CT data
were thus analyzed using generalized estimating equations (GEE)
model32 at each time point. A signiﬁcant difference was accepted
when P < 0.05.
Results
Evaluations of autologous EPC onto PLGA
We have previously characterized the phenotyping and geno-
typing of cultured rabbit EPC22. These cells uptake acetyl-LDL and
isolectin and express Flk-1 on the cell membrane. Most important,
the early EPC outgrow and form monolayer colonies with
“cobblestone” morphology after culturing in EGM-2 for 7 days
(Fig. 1). These EPC were subsequently harvested and then inocu-
lated in 3-D PLGA scaffolds for 24 h. The inoculated cells attached,
spread, and surrounded the inner and outer surface of the porous
scaffolds (Fig. 1). The overall cell attachment ratio was approxi-
mately 78  2.7% after 24 h of incubation, which was in line with
the absorbance of EPC using the MTS-based assay (the absorbance
value was 0.27  0.01 for EPC-seeded scaffolds and 0.04  0.01 for
scaffolds without cell seeding). Furthermore, ﬂuorescence-labeled
EPC were detected in the implanted site after 2 weeks, indicating
the successful homing and retention of the transplanted cells in the
PLGA scaffolds (Supplementary Data S4).
Tissue regeneration in rabbit osteochondral defects
The osteochondral regenerative response of autologous EPC-
seeded PLGA scaffolds under in situ physiological conditions was
determined by the creation of a full-thickness osteochondral defect
in the high weight-bearing zone of the medial condyle in rabbits
using a one-step surgery (Fig. 2).
4 weeks after implantation
The functional activities of all animals were recovered within 4
weeks after the implantations, and no infections or surgical com-
plications, such as stiff joints or contractures, were recorded.
Regarding gross appearance, the EPC-PLGA group showed a more
Fig. 1. EPC were subsequently harvested and then inoculated on a 3-D PLGA scaffold for 1 day. EPC (arrow) attached, spread, and surrounded the inner and outer surface of the
porous scaffolds, as determined by SEM images (middle) and the presence of ﬂuorescence-labeled EPC (right) with cell tracker (CM-DiI, Molecular Probes).
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defect, whereas the borders between the defect and the sur-
rounding cartilage were distinct in the ED and PLGA-only groups,
suggesting a poor integration of the regenerating and native car-
tilages in the ED and PLGA-only groups [Fig. 3(a)]. In addition, the
gross appearance scores were signiﬁcantly higher in the EPC-PLGA
group than in the ED (P < 0.001) and PLGA-only groups (P < 0.001)
[Fig. 3(b)].
Light microscopy showed that the osteochondral regeneration
in the EPC-PLGA group was characterized by visible chondroblasts
and immature chondrocytes and a greater amount of hyaline-like
cartilage tissues in the reparative defect region. Histological stain-
ings conﬁrmed more GAG, osteoid matrix, and the formation of
compact bone and the presence of osteoblasts in these sites (Fig. 4).
In contrast, in the PLGA-only and ED groups, the defects were ﬁlled
withmisaligned ﬁbrous tissues or poorly repaired tissues, including
predominantly ﬁbroblast-like cells with different degrees of stro-
mal hyalinization (Fig. 4). The formation of neovasculature with
CD31þ/vWFþ endothelial cell lining was detected at the central
regions of the EPC-PLGA grafts [Fig. 5(a)], while only very limited
angiogenesis was observed in the PLGA-only and ED groups. On the
other hand, the central regions of the osteochondral defect in the
non-EPC-treated animals were hemorrhagic and loaded with
edematous vesicles [Fig. 5(a)]. Quantitative measurements
conﬁrmed that the vascular density was signiﬁcantly higher in the
EPC-PLGA group (23.4  8.78) than in the ED (5.17  2.23) and
PLGA-only groups (10.17  2.93) (P < 0.001 and P ¼ 0.001, resp)
[Fig. 5(b)]. Furthermore, the matrix in the EPC-PLGA group con-
tained a considerable amount of ECM, COLI and collagen type II
(COLII) by immunostaining. The two critical endogenous growth
factors for osteochondral regeneration, namely, TGF-b2 and TGF-b3,
were also highly expressed in these sites 4 weeks after implanta-
tion (Fig. 6).Fig. 2. The schematic representative images of the one-step surgery of full-thickness oste12 weeks after implantation
Based on these changes during the early stage of regeneration,
we examined the osteochondral regeneration effects of EPC-PLGA
scaffolds 12 weeks after implantation. Surprisingly, the gross
appearance of the regenerated osteochondral defects in the EPC-
PLGA group showed newly grown cartilage tissue appearing in a
smooth, transparent and shiny articular surface that was not
distinguishable from the host cartilage tissue, indicating excellent
integration of the regenerated tissue and the neighboring cartilage
[Fig. 3(a)]. On the other hand, the PLGA-only and ED groups had
opaque tissues and osteoarthritic changes on the degenerative
articular surface [Fig. 3(a)], which is consistent with our previous
study12. Qualitative scores of the defect in the EPC-PLGA group
(10.38  0.32) were signiﬁcantly higher than those in the ED
(5.71  0.99) and PLGA-only (7.5  1.01) groups (P < 0.001 and
P ¼ 0.001, respectively), indicating superior osteochondral regen-
eration [Fig. 3(b)]. Histological examination further conﬁrmed that
the EPC-PLGA group showed the construction of nearly native hy-
aline cartilage that appeared in a normal columnar chondrocyte
arrangement with the expression of SOX9 and abundant GAG and
COLII content (Fig. 6). The regenerated tissues completely integrated
with the adjacent cartilage and bone. Furthermore, increased neo-
vascularizationwas indicated by the formation of CD31þ and vWFþ
endothelial cell lining at these sites [Fig. 5(c)]. In contrast, the PLGA-
only group exhibited mainly ﬁbrocartilaginous mixing with a
modest amount of GAG content (Fig. 4). The ED group displayed
ﬁbrous tissues with cell disarrangement and less GAG content
within the defect and depletion at the integration sites (Fig. 4). The
total histological scores were signiﬁcantly higher in the EPC-PLGA
group than in the ED and PLGA-only groups at week 12 (Table I);
in particular, the scores for surface morphology, cartilage thickness
and GAG content were remarkably higher in the EPC-PLGA group
than in the ED and PLGA-only groups (Supplementary Data S5).ochondral defects in the high weight-bearing zone of medial condyle of the rabbits.
Fig. 3. (a) Gross appearance of articular cartilage defects 4 and 12 weeks after operation. (b) The qualitative gross appearance score was signiﬁcantly higher in the EPC-PLGA group
than in the ED and PLGA-only groups.
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In the present study, a micro-CT system was used to assess the
quality and quantity of bone regeneration. At week 4, neo-osseous
tissue was regenerated from the edge toward the central region of
the defect site in all groups [Fig. 7(a)]. The formation of osteoid
matrix surrounded by osteoblasts within the pores of PLGA scaf-
folds was observed in the ED-PLGA group [Fig. 7(d)]. Bone volume
fraction, estimated by the BV/TV, was reduced following theFig. 4. The histological examinations of the ED, PLGA and EPC-PLGA groups 4 and 12 weeks a
collagen syntheses and alignment, H&E to assess the cell morphology, and Alcian blue stainin
of chondroblasts, greater GAG content, and the formation of osteoid matrix; however, the ED
cells. At week 12, the EPC-PLGA group showed enhanced hyaline cartilage regenerationwith
remodeled and native cartilaginous tissues. In contrast, the ED and PLGA-only groups sho
exhibited mainly ﬁbrocartilaginous tissue, and the ED group displayed ﬁbrous tissues with c
repaired tissue.creation of the osteochondral defect in the three treatment groups
[Fig. 7(b)]. At week 12, a newly synthesized mineral matrix in the
EPC-PLGA group was observed in the areas adjacent to the scaffolds
[Fig. 7(a)]. Architecture was formed in a well-integrated sub-
chondral trabecular bone formation with mature osteocytes
[Fig. 7(e)]. In comparison to ED (26.09  5.93) and PLGA-only
(34.93  6.52) groups, BV/TV and Tb.Th were signiﬁcantly higher
in the EPC-PLGA group (49.33  6.93), with values close to those
observed for the sham group (46.18  0.19) [Fig. 7(b and c)].fter implantation. The sections were stained byMasson’s trichrome to assess the overall
g to assess the GAG content. At week 4, the EPC-PLGA group showed a greater number
and PLGA-only groups showed poor ﬁbrous tissues with predominantly ﬁbroblast-like
a sound columnar chondrocyte arrangement and abundant GAG content in the adjacent
wed only modest GAG content in the defect sites. In addition, the PLGA-only group
ell de-arrangement. Square denotes magniﬁcation scale. Arrow shows the border of the
Fig. 5. Vascular formation in the subchondral bone of the repaired region. (a) 4weeks after the operation, the formation of neovasculature (v) with endothelial cell liningwas detected
at the central regionsof the PLGAgraft,while only very limitedvasculogenesiswas observed in the EDandPLGA-onlygroups.On the otherhand, the central regions of the osteochondral
defects in the non-EPC-treated animals were hemorrhagic (H) and contained edematous vesicles (Ev). In addition, scaffolds (Sc) were endocytosed by giant cells (Gc). (b)Vascular
density was signiﬁcantly higher in the EPC-PLGA group than in the ED and PLGA-only groups. (c) 12 weeks after the operation, signiﬁcantly more mature vascular structures were
generated in the repaired site with the presence of CD31þ and vWFþ cell lining. *: compared with the ED group at (P < 0.05); #: compared with the PLGA group (P < 0.01).
Fig. 6. Speciﬁc proteinswithin defect siteswere detected by IHC staining. 4weeks after implantation, thematrix in the EPC-PLGA group expressed a considerable amount of ECM, COLI
and COLII. TGF-b2 and TGF-b3 were also highly expressed at these sites. 12 weeks after implantation, the EPC-PLGA group contained nearly native hyaline cartilage with a normal
columnar chondrocyte arrangement and expressed higher levels of SOX9 and an abundance of GAG and COLII. Dash line indicates integration between host and regenerative tissues.
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Table I
Histological scores for the ED, PLGA and EPC-PLGA groups at 4 and 12 weeks. For each parameter, the values are expressed as the mean  95% CI
ED 4 weeks PLGA 4 weeks EPC-PLGA 4 weeks ED 12 weeks PLGA 12 weeks EPC-PLGA 12 weeks
Overall ﬁlling 1.5  0.57 1.8  0.39 2.0  0.51 1.86  0.28 1.83  0.33 2.14  0.28
Bone ﬁlling 1.75  0.49 1.8  0.39 1.83  0.32 1.71  0.56 1.67  0.41 2.43  0.40
Subchondral morphology 1.0  0.80 1.4  0.48 1.83  0.79 2.14  0.90 2.33  0.65 3.0  0.0*
Bone bonding 1.25  0.94 1.2  0.39 1.67  0.83 1.86  0.79 2.5  0.67* 2.29  0.56
Surface morphology 2.67  1.31 3.2  0.96 3.71  1.02 3.14  0.79 3.67  1.20 5.5  0.64*,y,z
Cartilage thickness 0.75  0.94 1.0  0.0 1.67  0.65 0.86  0.67 1.17  0.60 2.0  0.1937y,z
Surface regularity 1.0  0.80 1.2  0.39 1.33  0.65 1.43  0.84 1.67  0.41 2.0  0.60
Chondrocyte clustering 0.75  0.94 0.8  0.39 1.67  0.33 1.71  0.36 1.5  0.84 2.0  0.52*
GAG&Cell content of neo-surface 0.5  0.57 1.0  0.88 1.33  0.41 1.0  0.74 1.17  0.79 2.86  0.36*,y,z
GAG&Cell content of adjacent surface 1.25  0.49 1.4  0.48 1.67  0.41 1.57  0.72 2.17  0.60 2.29  0.36
Total 11.75  4.89 14.8  3.12 20  4.53y,z 19.33  4.34 21.4  3.54* 28.14  2.07*,y,z
PLGA degradation 1.0  0.62 1.5  0.44 1.5  0.83 2  0.60
* Compared to 4 weeks postoperation (P < 0.05).
y Compared with the ED group at the same time point (P < 0.01).
z Compared with the PLGA group at the same time point (P < 0.01).
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In the present study, we demonstrated that the transplantation of
EPC seeded in 3D PLGA grafts enhances the formation of hyaline
cartilage and the neovascularization in the subchondral bone of
osteochondral defects. Most important, we present the ﬁrst study
supporting that modulation of the in situmicroenvironments for the
functional remodeling of osteochondral defects by increasing the
formation of neo-hyaline cartilage and the growth of columnar
roundedchondrocyteswithenriched synthesis of collagen II andGAG.
Furthermore, we highlight that this cell-based therapeutic approach
was achieved without the supplement of exogenous growth factors.Fig. 7. Analysis of bone regeneration. (a) At week 4 after implantation, neo-osseous tissue wa
newly synthesized mineral matrix in the EPC-PLGA group was observed in the areas adjacen
(c) the thickness of trabecular bone (Tb.Th) were calculated. (d) At week 4 after implantat
within pores of the scaffold was observed in the ED-PLGA group. (e) At week 12 (right ima
osteocytes (Oc) (arrows). *: compared with the ED group at (P < 0.01); #: compared withDespite the advances in conventional surgical techniques in
articular cartilage repair, the formation of ﬁbrocartilage tissues in
the replacement of hyaline cartilage eventually leads to the
development of osteoarthritis in the defect joints. Recent progress
in osteochondral regeneration has focused on (1) autologous cell
origin for minimal immune responses, (2) engineered scaffolding
substitutes in providing a provisional space for effective tissue
regeneration, and (3) the manipulation of appropriate bio-
environments for cell proliferation and differentiation. Therefore,
it is essential to develop an autologous cell-based therapy in
combination with a biocompatible scaffold system to generate a
suitable microenvironment for osteochondral regeneration.s regenerated from the edge to the middle region of the defect in all groups, and a more
t to the scaffolds at week 12. (b) The ratio of bone volume to tissue volume (BV/TV) and
ion (left image), the formation of osteoid matrix (Os) surrounded by osteoblasts (Ob)
ge), well-integrated subchondral trabecular bone (Tb) was formed with more mature
the PLGA group (P < 0.01); &: compared with the sham group (P < 0.05).
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technically challenging and expensive, requires longer isolation and
culturing times and two-step surgery, and, most undesirably, en-
ables the formation of ﬁbrocartilage. BMSCs have been attractive
therapeutic candidates for orthopedic applications. However, the
isolation of BMSCs usually requires painful surgical interventions
and supplementary growth factors for cell differentiation.
PLGA scaffolds with proper pore sizes serve as a suitable matrix
that provides anattachedbiocompatible environment for EPC (Fig.1).
These scaffolds provide amechanical support for stem cells and serve
as a 3D topographical cue for stem cell migration, attachment and
homing at the site of the defect. Apart from direct cell fusion, the
release of bioactive growth factors or cytokines stimulates cell pro-
liferation and directs cell differentiation into the specialized cells or
tissues. Therefore, our delivery system incorporating EPC with PLGA
scaffolds theoretically provides abiological cue to recruit surrounding
cells and offers a vessel-richmicroenvironment for nutrition support
in the regenerating joint tissue (Figs. 4e6). In comparison to the
placebo and the PLGA-only treatment groups, the EPC-PLGA complex
generated a considerably higher amount of ECM and collagen I/II in
the defect joints. To further characterize this phenomenon, we
determined the levels of two critical growth factors for osteochondral
regeneration in the tissues, namely, TGF-b2 and TGF-b3. The TGF-b
superfamily regulates several important down-stream molecules in
the control of cell proliferation, differentiation, and tissue regenera-
tion33. TGF-b2 and TGF-b3 have been demonstrated to mediate
important responses in cartilage and bone regeneration in vitro34,35
and in vivo36,37. In line with these previous reports, we found that
knees implanted with EPC-PLGA expressed considerably high tissue
levelsof TGF-b2andTGF-b3 in the repaired sites (Fig. 6). Furthermore,
more GAG was synthesized in the adjacent remodeled and native
cartilaginous tissues, whereas the ED and PLGA-only groups showed
only modest GAG content in the defect sites (Fig. 4). Using the Alcian
blue stain, we conﬁrmed the presence of new chondrocytes within
the cartilaginous areas of the spongiosal bone, or so-called primary
spongiosa, in the deep region of the grafting site (Fig. 4). This phe-
nomenon reveals that trabeculae are present in the calciﬁed cartilage
core until all the trabeculae are eroded from their surfaces and
removedbyosteoclasts38. Therefore, the transplantationof EPC in the
PLGA scaffolds appeared to direct the regenerative process in the
osteochondral defects by generating hyaline cartilage, while the ED
and PLGA-only groups showed the formation of mainly ﬁbrous or
ﬁbrocartilage tissues. These molecular and histological changes
(Figs. 4 and 6) are consistent with the ﬁndings under micro-CT ex-
amination (Fig. 7), which showed that EPC-PLGA treatment provided
signiﬁcantly higher bone matrix and structurally adequate primary
biomechanical stability in the repaired cartilage. The mechanical re-
covery of healing cartilage correlates with the subchondral bone
regeneration39. Our present study design did not provide direct
evidence for the ﬁnal fate of the transplanted EPC, as these endo-
thelial progenitors may transdifferentiate into other mesenchymal
cells, i.e., chondrocytes. Nevertheless, this cell- and scaffold-based
tissue engineering approach is the ﬁrst study demonstrating that
highly angiogenetic EPC provide beneﬁts in hyaline cartilage regen-
eration associated with sound underlying bone regeneration in
osteochondral defects. To our knowledge, only one previous study
has suggested that endothelial cells transdifferentiate into
mature chondrocytes and osteocytes through the endothelial-to-
mesenchymal transition in an experimental model of ﬁbrodysplasia
ossiﬁcans progressive40. However, the limitation of present study is
that the direct mechanisms underlying the role of EPC in cartilage
repair and their interaction with surrounding tissues remain un-
known and need to be addressed in future research.
In conclusion, we demonstrated that pre-seeding EPC onto
highly porous, biocompatible PLGA scaffolds creates a favorable insitu microenvironment for the regeneration of osteochondral re-
gions by facilitating chondrocyte growth and hyaline cartilage
synthesis and providing sound, complete osteochondral integration
and a vascularized bonematrix. As opposed to traditional therapies,
this implantation scaffold also provides a simple, effective, and
clinically feasible cell transplantation system to enable the gener-
ation of hyaline cartilage and bone tissue regeneration without the
supplement of exogenous growth factors.
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